Molecular Testing in Metastatic Gastric/GEJ Cancer
2 Views
administrator
06/30/23
David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.
-
Category
Show more
Facebook Comments
No comments found